Journal:
:hepatitis monthly
0
jamal sarvari institute for cancer research, shiraz university of medical sciences, shiraz, ir iran; department of bacteriology and virology, shiraz university of medical sciences, shiraz, ir iran; department of biochemistry and functional proteomics, yamaguchi university graduate school of medicine, yamaguchi, japan
zahra mojtahedi institute for cancer research, shiraz university of medical sciences, shiraz, ir iran
seyed ali reza taghavi department of internal medicine, shiraz university of medical sciences, shiraz, ir iran
yasuhiro kuramitsu department of biochemistry and functional proteomics, yamaguchi university graduate school of medicine, yamaguchi, japan
mahmoud shamsi shahrabadi department of virology, tehran university of medical sciences, tehran, ir iran
abbas ghaderi institute for cancer research, shiraz university of medical sciences, shiraz, ir iran; institute for cancer research, shiraz university of medical sciences, shiraz, ir iran. tel: +98-7112303687, fax: +98-7112304952
conclusions cd5l might be a useful biomarker for early diagnosis of hcc in hcv cirrhotic patients. lrg and hp α2 isoforms could be potential markers for distinguishing viral hcc. our results also further support the presence of varying molecules involved in hepatocarcinogenesis in hbv when compared with hcv infection. patients and methods two-dimensional polyacrylamide gel electrophoresis combi...
